BLANDINO, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 7.900
EU - Europa 4.590
AS - Asia 3.685
SA - Sud America 639
AF - Africa 439
Continente sconosciuto - Info sul continente non disponibili 254
OC - Oceania 5
Totale 17.512
Nazione #
US - Stati Uniti d'America 7.551
SG - Singapore 1.879
IT - Italia 1.276
RU - Federazione Russa 1.136
CN - Cina 1.106
UA - Ucraina 786
IE - Irlanda 629
BR - Brasile 507
VN - Vietnam 286
CA - Canada 275
CI - Costa d'Avorio 273
FR - Francia 226
SE - Svezia 153
GB - Regno Unito 103
KR - Corea 91
DE - Germania 76
NG - Nigeria 65
IN - India 64
NL - Olanda 49
BD - Bangladesh 46
AR - Argentina 39
HK - Hong Kong 34
MX - Messico 33
EC - Ecuador 31
PL - Polonia 30
CO - Colombia 26
IQ - Iraq 26
ID - Indonesia 25
SN - Senegal 23
ZA - Sudafrica 22
CH - Svizzera 21
PK - Pakistan 21
AT - Austria 18
TR - Turchia 18
UZ - Uzbekistan 18
VE - Venezuela 16
ES - Italia 15
MA - Marocco 14
JP - Giappone 12
GR - Grecia 11
JM - Giamaica 11
BE - Belgio 9
CZ - Repubblica Ceca 9
EG - Egitto 9
EU - Europa 9
FI - Finlandia 9
KE - Kenya 9
LB - Libano 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
CL - Cile 6
DZ - Algeria 6
LT - Lituania 6
AU - Australia 5
GT - Guatemala 5
IR - Iran 5
SA - Arabia Saudita 5
BO - Bolivia 4
HN - Honduras 4
IL - Israele 4
PE - Perù 4
RO - Romania 4
TN - Tunisia 4
AM - Armenia 3
BG - Bulgaria 3
BJ - Benin 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HR - Croazia 3
HU - Ungheria 3
MD - Moldavia 3
OM - Oman 3
PS - Palestinian Territory 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
BF - Burkina Faso 2
BS - Bahamas 2
ET - Etiopia 2
GA - Gabon 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
SV - El Salvador 2
AD - Andorra 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GP - Guadalupe 1
KW - Kuwait 1
Totale 17.262
Città #
Dallas 1.149
Singapore 1.027
Santa Clara 880
Jacksonville 751
Dublin 627
Chandler 572
San Jose 563
Moscow 459
Ashburn 369
Boardman 290
Abidjan 273
Nanjing 216
Los Angeles 206
Chicago 201
Toronto 183
Lawrence 178
Andover 176
Cambridge 176
Lauterbourg 160
Beijing 154
Hefei 138
San Mateo 122
Council Bluffs 111
Ho Chi Minh City 102
Milan 93
Wilmington 89
Seoul 88
Des Moines 83
Catania 69
Hanoi 60
Nanchang 60
Shenyang 59
Rome 56
Civitanova Marche 55
Hebei 52
Jiaxing 49
Houston 48
Ottawa 47
Saint Petersburg 43
São Paulo 42
Tianjin 39
Abuja 36
Amsterdam 34
New York 34
Changsha 33
Buffalo 27
Lagos 27
Bremen 25
Hong Kong 24
Dakar 23
Columbus 21
Da Nang 21
London 21
Montreal 21
Boston 20
Florence 20
Seattle 19
Atlanta 18
Rio de Janeiro 18
Warsaw 18
Brooklyn 17
Phoenix 17
The Dalles 17
Haiphong 16
Orem 16
Denver 15
Palermo 15
Johannesburg 14
Baghdad 13
Bologna 13
Dhaka 13
Hangzhou 13
Stockholm 13
Belo Horizonte 12
Chennai 12
Mexico City 12
Norwalk 12
Turin 12
Verona 12
Cherasco 11
Mumbai 11
Pune 11
San Francisco 11
Washington 11
Ann Arbor 10
Curitiba 10
Genoa 10
Poplar 10
Jinan 9
Manchester 9
Porto Alegre 9
Quito 9
Tokyo 9
Angri 8
Ankara 8
Brasília 8
Brussels 8
Den Haag 8
Frankfurt Am Main 8
Guayaquil 8
Totale 11.035
Nome #
Caratteristiche di adesione di ceppi di Bifidobacterium lactis BB-12, Bifidobacterium longum W11, Bifidobacterium bifidum su cellule epiteliali umane della linea HT-29 1.062
Antibiotic susceptibility profiles of uncommon bacterial species causing severe infections in Italy 215
In vitro inhibitory activity of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 alone or in combination against bacterial and Candida reference strains and clinical isolates 214
A novel delta-hemolysis screening method for detecting heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-inermediate S.aureus 184
3-Methylthio-, 3-(amino-substituted)ethylthio-, 3-carboxymethylthio-, 3,3'-(dithiobis)-5-aryl-4H(R)-1,2,4-triazoles and 2-aminomethyl-N-substituted derivatives of 5-aryl-4H(R)-1,2,4-triazolin-3-thione: synthesis and biological activity 172
Chemical and biological properties of the novel exopolysaccharide produced by a probiotic strain of Bifidobacterium longum 165
Antibacterial activity of medicinal plant extracts against periodontopathic bacteria 158
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 154
Ampliamento dello spettro di attività della vancomicina nei confronti di batteri gram-negativi mediante incapsulazione in liposomi fuso genici 151
CARATTERISTICHE DI ADESIONE DI CEPPI DI BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS BB-12, BIFIDOBACTERIUM LONGUM W11, BIFIDOBACTERIUM BIFIDUM SU CELLULE EPITELIALI UMANE DELLA LINEA HT-29 151
Impact of gut microbiota on diabetes mellitus 147
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 147
Batteri anaerobi non sporigeni. In: MICROBIOLOGIA FARMACEUTICA 139
Activity of Berberis aetnensis C. Presl. Root extract against Candida strains 134
Microbial and clinical effects of systemic flurithromycin therapy in the treatment of periodontal diseases compared with clinical procedures 134
Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections 132
Antimicrobial susceptibility and Beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections 130
Antimicrobial susceptibility of Lactobacillus strains used in probiotic products 130
Microbial evaluation of "in vitro" antibacterial activity of "one stage full mouth" disinfection with clorexidine in adult periodontitis 129
BACTERIOLOGICAL STUDIES OF AMOXYCILLIN-CLAVULANIC ACID AGAINST ANEROBIC BACTERIA. 127
Effect of a broad-spectrum cephalosporin on the oral and intestinal microflora in patients undergoing colorectal surgery 126
Comparison of systemic flurithromycin therapy and clinical procedures in the treatment of periodontal diseases 125
Isolation and characterization of promising probiotic lactobacilli and bifidobacteria from stools of breast-fed infants and honeybees’ gut 125
Antimicrobial susceptibility of Lactobacillus species used in probiotic products 124
Microbiological and clinical periodontal effects of fixed orthodontic appliances in pediatric patients 124
Bacteriological findings and antimicrobial resistance in odontogenic and non odontogenic chronic maxillary sinusitis 122
Antibiotic prescribing for dental conditions: a community-based study in southern Italy 122
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 121
Identification and characterization of Lactobacillus paracasei strain with probiotic properties isolated from faeces of healthy adult volunteers 119
Antibacterial activity and post-antibiotic effect of flurithromycin compared with other macrolides and penicillins against periodontal pathogens 118
Antimicrobial susceptibility of strains of Enterobacteriaceae isolated from bloodstream infections using current CLSI and EUCAST breakpoints 118
Bacilli sporigeni aerobi e anaerobi (cap. 37) 117
SENSITIVITY TO AUGMENTIN OF ANEROBIC BACTERIA BETA-LACTAMASES PRODUCING. 116
Bacilli sporigeni aerobi ed anerobi. In: MICROBIOLOGIA FARMACEUTICA 116
Aztreonam versus gentamicin in short-term prophylaxis in biliary and gastric surgery 116
Attività antibatterica di cefprozil nei confronti di Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis e Streptococcus pneumoniae circolanti attualmente in Italia 113
Epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated from 2001 to 2005 in Catania 113
Antimicrobial susceptibility of anaerobic and facultative aerobic bacteria isolated from pus specimens of orofacial infections and beta-lactamase production 113
Antibacterial activity of moxifloxacin against pathogens related with respiratory tract infections 112
Antibiotic susceptibility of bacterial isolates from probiotic products available in Italy 112
Bactericidal activity and postantibiotic effect of cefdnir (ci 983, fk 482) against selected athogens 111
Parodontopatia dell'adulto: 3 terapie a confronto 110
Intercellular communication during yeast cell growth 107
Synthesis of 1-aroyl-4H(R)-thiosemicarbazides, the corresponding 5-aryl 4H(R)-1,2,4-triazolin-3-thiones and some derivatives of pharmaceutical interest 107
Growth and adhesion to HT-29 cells inhibition of gram-negatives by Bifidobacterium longum BB536 e Lactobacillus rhamnosus HN001 alone and in combination 107
Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains 107
Reactivity of 3-aryl-4-amino-5-mercapto-4H-1,2,4-triazoles: synthesis and biological evaluation of 3,6-diaryl derivatives of 7H-1,2,4-thiazole[3,4-b][1,3,4]thiadiazines, of 3-aryl-4-amino-5-carboxymethylthio-4H-1,2,4-triazoles 105
Synthesis and antimicrobial evaluation of 4-phenyl-3-isoquinolinoyl-hydrazones 104
Streptococcus pyogenes emm types and subtypes of isolates from paediatric asymptomatic carriers and children with pharyngitis 104
DIMINUITA PRESENZA DI FATTORI DI VIRULENZA IN ESCHERICHIA COLI UROPATOGENI ANTIBIOTICO-RESISTENTI 104
Synthesis and preliminary biological investigation of 2,6-diaryl substituted imidazo(1,2-b)-1,3-4-thiadiazoles [SINTES]I E VALUTAZIONE BIOLOGICA PRELIMINARE DI IMIDAZO[2,1-b]-1,3,4-TIADIAZOLI-2,6-DIARILSOSTITUITI 103
Studio microbiologico dell’attività antibatterica “in vivo” della disinfezione “one stage full mouth” con clorexidina nella terapia della parodontite dell’adulto 102
Probiotics:overview of microbiological and immunological characteristics 101
Prevenzione e controllo delle infezioni in chirurgia gastrica 100
Virulence factors and antibiotic resistance in uropathogenic Escherichia coli 100
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 100
Uso di prebiotici e probiotici ed ecosistema microbico intestinale 99
SURGICAL SITE INFECTION IN ELDERLY PATIENTS 99
Microbiological characteristics of kanendomycin [Caratteristiche microbiologiche della kanendomicina] 99
Meccanismi patogenetici di ceppi di Prevotella intermedia e Fusobacterium nucleatum isolati da parodontopatie e da infezioni polmonari 98
Bactericidal kinetics and postantibiotic effect of Ciprofloxacin against B. catarrhalis, H. influenzae and S. pneumoniae 97
Synthesis, spectral behaviour and microbiological properties of some di(nitrothienyl)sulfides. 97
Osservatorio Epidemiologico Italiano: analisi del secondo anno di monitoraggio delle resistenze agli antibiotici in Haemophilus influenzae e Haemophilus parainfluenzae 97
Microbiological intraoperative results in short-term prophylaxis (aztreonam or gentamicin) in abdominal surgery 97
Complete Genome Sequence of Bifidobacterium longum W11 (LMG P-21586), Used as a Probiotic Strain 97
Colorectal surgery: short-term prophylaxis with clindamycin plus aztreonam or gentamicin 96
In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections 96
Dental implants with locking taper connection versus screwed connection: microbiologic and scanning electron microscope study 95
Aztreonam versus gentamicin for short-term prophylaxis in biliary and gastric surgery 95
SUSCEPTIBILITY OF CLINICAL ISOLATES OF ENTEROBACTERIACEAE TO CEFDINIR (CI 983, FK 482) 94
Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy 94
CT findings in hepatic involvement by Echinococcus granulosus 94
Osservatorio Epidemiologico Italiano. Patogeni respiratori comunitari e nosocomiali: analisi delle resistenze nel 1997. Haemophilus influenzae, Haemophilus parainfluenzae e Moraxella catarrhalis 93
Caratterizzazione molecolare di ceppi di Lactobacillus spp. utilizzati in prodotti probiotici vaginali e determinazione della sensibilità agli antibiotici 93
Probiotici e Prebiotici:dalla ricerca al consumatore 93
Predictive value of bacterial analysis of laparotomy wounds 93
Susceptibility of clinical isolates of Haemophilus to new 4-quinolones 92
PRODUZIONE DI B-LATTAMASI ED ANTIBIOTICO SENSIBILITA’ DI GERMI ANAEROBI. 92
Incidence of non-fermenting gram-negative bacilli in infected patients 91
Immunizzazione passiva naturale e artificiale. In: MICROBIOLOGIA FARMACEUTICA 90
Antimycotic effect of diaryl sulfides with open chains and ring systems containing pyridine and thiadiazole units [Azione antimicotica di alcuni diaril solfuri a catena aperta e ciclici contenenti unità piridiniche e tiadiazoliche] 89
Studio microbiologico dell'attività "in vivo"della disinfezione "one stage full mouth"con clorexidina nella terapia della parodontite dell'adulto 89
Evaluation of the antibacterial effect of cefsulodin against Pseudomonadaceae [Valutazione dell'attività antibatterica del cefsulodin nei confronti di Pseudomonadaceae] 89
Susceptibility of molecularly characterizeted hospital-associated methicillin-resistant Staphylococcus aureus isolates to dalbavancin 89
Batteri anaerobi non sporigeni (cap. 38) 88
Activity of Ciprofloxacin against Respiratory Pathogens Capable of Producing β-Lactamase 87
Incidence of fermentative and non-fermentative gram-negative bacilli in an intensive care environment [Incidenza di bacilli gram-negativi fermentanti e non fermentanti in ambiente nosocomiale di terapia intensiva] 86
In vitro activity of imipenem towards gram-negative bacilli 85
Impianti dentali a connessione conometrica versus impianti dentali a connessione avvitata:studio microbiologico e al microscopio elettronico a scansione 85
Caratteristiche microbiologiche e terapeutiche dei batteri probiotici 85
Effetto prebiotico di Opuntia ficus-indica (L.) nei confronti di alcuni ceppi di Lactobacillus e Bifidobacterium isolati da prodotti probiotici farmaceutici 85
Incidence and antibiotic-resistance of gram-negative species isolated from burns [Incidenza antibiotico-resistenza di specie batteriche gram-negative isolate in ustionati] 84
Correlations between bacterial flora present in the juice and the gastric mucosa and the risk of postoperative infection [Correlazione tra flora batterica presente nel succo e nella mucosa gastrica e rischio di infezione postoperatoria] 84
L'ambiente intestinale e la disbiosi 84
Aspetti microbiologici in chirurgia biliare 84
L'ofloxacin nel trattamento delle infezioni alte vie respiratorie 83
Microbiological evaluation of 6-beta-amidino-penicillanic acid (mecillinam) 83
Internalization–associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis 83
In vitro activityof Cefdinir against respiratory pathogens 81
Microbiological characteristics of the probiotic strains B. longum BB536 and L. rhamnosus HN001 used in combination 81
Totale 12.004
Categoria #
all - tutte 57.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022992 0 0 13 33 205 8 198 43 158 3 54 277
2022/20231.899 187 60 26 131 243 339 13 299 506 23 56 16
2023/2024796 49 115 39 66 36 78 29 60 23 48 162 91
2024/20253.111 39 480 198 144 780 267 32 121 244 320 186 300
2025/20266.543 434 394 1.395 384 969 1.237 806 128 282 312 134 68
2026/2027541 143 364 34 0 0 0 0 0 0 0 0 0
Totale 17.512